Stockreport

Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025

Gain Therapeutics, Inc.  (GANX) 
PDF GT-02287 reduces mitochondrial stress and enhances neuronal survival in MPP+ treated rat dopaminergic neurons GT-02287 decreases staining for MIRO1, suggesting improved [Read more]